Spectrum Pharmaceuticals Inc (SPPI.OQ)
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|82||2017||Chairman of the Board|
|60||2017||President, Chief Executive Officer, Director|
|50||2013||Chief Financial Officer, Executive Vice President|
|42||2017||Chief Operating Officer, Chief Commercial Officer, Executive Vice President|
- BRIEF-Spectrum Pharmaceuticals Reports Q1 Non-GAAP Loss Per Share $0.15
- BRIEF-Spectrum Pharmaceuticals Enters Into A Next-Generation Sequencing Companion Diagnostic Partnership With Thermo Fisher Scientific
- US STOCKS-Wall St hits session highs as trade war worries fade
- BRIEF-Shrotriya May Sell Up To 1 Mln Shares Of Spectrum Pharmaceuticals' Common Stock
- BRIEF-Spectrum Pharma Q4 Loss Per Share $0.29